Real-time enrollment status for this advanced cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:04 PM UTC
| NCT Number | NCT05270213 |
| Recruiting Status | Recruiting |
| Condition | Advanced Cancer |
| Phase | PHASE1 |
| Target Enrollment | 164 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Riboscience, LLC. |
| Last Updated on CT.gov | December 19, 2025 (Dec 19, 2025) |
As of October 12, 2026: Clinical trial NCT05270213 is currently recruiting participants. This phase1 study for advanced cancer is actively seeking new participants at 14 locations across the United States. The study is sponsored by Riboscience, LLC.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05270213 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05270213 was last updated Dec 19, 2025 (December 19, 2025). HelloStudys verifies this status automatically.